These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29266238)

  • 1. Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?
    Yi M; Cai J; Li J; Chen S; Zeng Z; Peng Q; Ban Y; Zhou Y; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Aug; 233(8):5537-5549. PubMed ID: 29266238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
    Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
    Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
    Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
    Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ
    Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape.
    Bruce JP; To KF; Lui VWY; Chung GTY; Chan YY; Tsang CM; Yip KY; Ma BBY; Woo JKS; Hui EP; Mak MKF; Lee SD; Chow C; Velapasamy S; Or YYY; Siu PK; El Ghamrasni S; Prokopec S; Wu M; Kwan JSH; Liu Y; Chan JYK; van Hasselt CA; Young LS; Dawson CW; Paterson IC; Yap LF; Tsao SW; Liu FF; Chan ATC; Pugh TJ; Lo KW
    Nat Commun; 2021 Jul; 12(1):4193. PubMed ID: 34234122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
    Li YY; Chung GT; Lui VW; To KF; Ma BB; Chow C; Woo JK; Yip KY; Seo J; Hui EP; Mak MK; Rusan M; Chau NG; Or YY; Law MH; Law PP; Liu ZW; Ngan HL; Hau PM; Verhoeft KR; Poon PH; Yoo SK; Shin JY; Lee SD; Lun SW; Jia L; Chan AW; Chan JY; Lai PB; Fung CY; Hung ST; Wang L; Chang AM; Chiosea SI; Hedberg ML; Tsao SW; van Hasselt AC; Chan AT; Grandis JR; Hammerman PS; Lo KW
    Nat Commun; 2017 Jan; 8():14121. PubMed ID: 28098136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational genomics of nasopharyngeal cancer.
    Tsang CM; Lui VWY; Bruce JP; Pugh TJ; Lo KW
    Semin Cancer Biol; 2020 Apr; 61():84-100. PubMed ID: 31521748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
    Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
    J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
    Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
    Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.
    Valentine R; Dawson CW; Hu C; Shah KM; Owen TJ; Date KL; Maia SP; Shao J; Arrand JR; Young LS; O'Neil JD
    Mol Cancer; 2010 Jan; 9():1. PubMed ID: 20051109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
    Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
    Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
    Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
    BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells.
    Port RJ; Pinheiro-Maia S; Hu C; Arrand JR; Wei W; Young LS; Dawson CW
    J Pathol; 2013 Nov; 231(3):367-77. PubMed ID: 23934731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.
    Zheng H; Dai W; Cheung AK; Ko JM; Kan R; Wong BW; Leong MM; Deng M; Kwok TC; Chan JY; Kwong DL; Lee AW; Ng WT; Ngan RK; Yau CC; Tung S; Lee VH; Lam KO; Kwan CK; Li WS; Yau S; Chan KW; Lung ML
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11283-11288. PubMed ID: 27647909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.